Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xavier Avat Insider Profile
4 Followers
Xavier Avat, Former CBO at Capricor Therapeutics, holds 0.00 shares in Capricor Therapeutics (Ticker: CAPR). Most recently, Xavier Avat Sold $14,772 shares of Capricor Therapeutics on Apr 27, 2023 for an estimated value of 949.22M.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-19.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Xavier Avat does not currently own shares as a corporate insider.
A breakdown of Xavier Avat's holdings
Insider Roles
Former CBO
Roles that Xavier Avat holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 07, 2022 - Jul 07, 2023
Return:+1.00%
The most profitable trade made by Xavier Avat
Xavier Avat's Trading History
List of latest transactions for each holding click on a transaction to see Xavier Avat's performance on stock
You May Also Like
Xavier Avat insider profile FAQ
What is the percentage of profitable transactions made by Xavier Avat?
The percentage of profitable transactions made by Xavier Avat is 50%.
What is the average return per transaction made by Xavier Avat?
The average return per transaction made by Xavier Avat is -19.20%.
What stocks does Xavier Avat hold?
Xavier Avat holds: CAPR stocks.
What was Xavier Avat’s latest transaction?
Xavier Avat latest transaction was an Informative Sell of $949.22M.
What was Xavier Avat's most profitable transaction?
Xavier Avat’s most profitable transaction was an Informative Buy of CAPR stock on July 7, 2022. The return on the trade was 1.00%.
What is Xavier Avat's role in Capricor Therapeutics?
Xavier Avat's role in Capricor Therapeutics is Former CBO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.